The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.

In September 2025, the Russian Ministry of Health issued a registration certificate for a new dosage form of the broad-spectrum antiviral drug TRIAZAVIRIN® for the treatment of ARVI in school-age children—100 mg.

On October 10, 2025, a representative delegation visited the Medsintez Plant. Among the visitors, there were members of the State Duma of the Russian Federation, representatives of the Government and Legislative Assembly of the Sverdlovsk Region, the head of the Novouralsk Urban District, and leading regional experts in the field of medical science. The main purpose of the visit was to assess the enterprise's success in import-substituting drug production, become familiar with its brand-new products, and discuss development options of the pharmaceutical industry in the region.

Current data on modern approaches to the therapy of acute respiratory viral infections (ARVI) in children were presented at the VI Congress of Children's Physicians of the Moscow Region with international participation «Pediatrics as an Art» (September 3–5, 2025). Zhdanov K. V., Doctor of Medical Sciences, Professor, Director of the Scientific and Clinical Center of the Federal State Budgetary Institution «Federal Scientific and Clinical Center of Infectious Diseases of the Federal Medical and Biological Agency of Russia», corresponding member of the Russian Academy of Sciences, and honored scientist of the Russian Federation, delivered a key report titled «Current Issues of the ARVI Therapy in Children. New Data.»